Table 3 Treatments and Disease characteristics in patients with local disease
From: Breast cancer in moroccan young women: a retrospective study
Characteristic | No. of patients | (%) |
|---|---|---|
No. of patients | 356 | 100 |
Tumor size | ||
T1 | 48 | 13.5 |
T2 | 161 | 45.2 |
T3 | 71 | 19.9 |
T4 | 76 | 21.3 |
N Statut | ||
N0 | 107 | 30.1 |
N1 | 74 | 20.8 |
N2 | 93 | 26.1 |
N3 | 82 | 23 |
HER 2 | ||
HER 2 negative | 23 | 48.9 |
HER 2 positive | 24 | 51.1 |
TNM | ||
Stage I | 30 | 8.4 |
Stage II | 140 | 39.3 |
Stage III | 186 | 52.2 |
Surgery | ||
Yes | 347 | 97.5 |
No | 9 | 2.5 |
Surgery type | ||
Radical mastectomy | 265 | 76.8 |
Concerving surgery | 80 | 23.2 |
Radiotherapy | ||
Yes | 290 | 81.5 |
No | 66 | 18.5 |
Neoadjuvante chemotherapy | ||
Yes | 76 | 21.3 |
No | 280 | 78.7 |
Neoadjuvante chemotherapy type | ||
Anthracycline | 69 | 90.8 |
CMF | 5 | 6.6 |
AC60/TAXANE | 2 | 2.6 |
Histological response to neoadjuvante chemotherapy | ||
Chevalier 1 | 2 | 2.6 |
Chevalier 2 | 6 | 7.9 |
Chevalier 3 | 38 | 50 |
Chevalier 4 | 30 | 39.5 |
Adjuvant chemotherapy | ||
Yes | 311 | 87.4 |
No | 45 | 12.6 |
Adjuvant hormonotherapy | ||
Yes | 232 | 64.6 |
No | 124 | 35.4 |